These results provide evidence that USP24 inhibition via WP1130 potentiates ferroptosis in TNBC cells, reinforcing the therapeutic potential of targeting USP24 to enhance ferroptosis-driven anti-cancer strategies. Here, USP24 is linked to cancer.